BLOG
ABOUT
SUBSCRIBE
A QA Perspective on Working with New Clinical Research Sites
Posted by
Lorrie Divers
,
April 12, 2010, 2:34 AM
How difficult is it to train and set up investigator sites that have never been involved in clinical research
This question was posed to myself and other members of the
Clinical Research Professionals group
on LinkedIn. Thorough Good Clinical Practices (GCP) training, careful consideration of the site's capabilities, personnel resources, and commitment from the principal investigator (PI) are all important. However, in my opinion there are several other factors also critically important for a successful naive clinical research site.
1)
Practical training in managing the routine and non-routine tasks of conducting a clinical trial.
Much the process can be described in SOPs, however, for staff who has never conducted a clinical trial before, many of the things experienced personnel take for granted will be new and unknown. For example, they need to understand not only the importance of using the current, IRB-approved version of the informed consent form, but how to actually control the document to ensure that is done consistently and easily. They need to understand how to keep accurate investigational drug accountability records with periodical review the inventory, compare them to the accountability record and identify and investigate/correct any discrepancies in “real time” rather than 14 months later.
2)
A site-specific monitoring plan and an experienced monitor who will be given adequate time to support the site, both remotely and with frequent monitoring visits.
Such plans should include visits focused on GCP compliance, not just source data verification and case report forms; they should help control
enrollment
and not allow a naive site to
enroll
a large amount subjects right at the very start without visiting very early (even just after the first subject) to monitor and assess how well the site has adhered to eligibility, consent,
enrollment
and protocol requirements; and plans should outline frequent contact among the monitor and study site between monitoring visits to answer questions and provide suggestions, encouragement and support.
There must be a substantial time and resource commitment on the part of the sponsor/CRO to really support and continually train the naive study site staff and PI, not just train them at the initiation visit or investigator meeting.
3)
A dedicated clinical research coordinator (CRC)
By "dedicated" I mean not only a person who is interested and willing, but one who is specifically tasked with being the study coordinator, is given adequate time and support to do so (not just adding 4 more hours of work to an already 8 hour work day). They need to be able to work effectively with the PI and with whom the PI will work effectively and support, and of course, who is trained and supported by the monitor as described above. In my experience, the lack of a dedicated (in both senses of the word) CRC is one of the most significant failures for both research naive and research experienced study sites.
Central labs and CROs have to be willing to help new investigators and new study sites become involved in clinical research in order to meet the demands of the drug and device development business and the ever increasing pressures of rapid recruitment and study completion time lines. But we also have to be willing to provide them with the training, support, and monitoring to allow them to be successful. If a new PI has a bad experience - for example, a very negative sponsor audit or an FDA inspection - they are not likely to ever be a PI again.
What is your list of success factors when working with new investigator sites?
Category:
Quality Assurance
Share
Mixx
Digg
Facebook
del.icio.us
Twitter
MySpace
StubmleUpon
|
1
comments
|
Add a comment
Comments
Clinical Research Courses
8/16/2010 06:23:15 AM
What a tremendous article written on Clinical Research site training. It was a really interesting read. I would like to read more such articles. Thanks for sharing! http://www.clinimis.info/
1
Leave Your Comment
(
Comment Guidelines and Policies
)
Name:
(required)
Email:
(required but will not be displayed)
Comment:
(max 1500 characters)
Character count:
0
SEARCH BLOG
Keywords:
Category:
- All -
Clinical Trials Testing
Data Management
Global Clinical Trials
Logistics
Quality Assurance
Specimen Management
RECENT TWEETS
Do you want know more about our partnership with Cryoport for cost-effective dry vapor shipping? Read Tracy... http://t.co/5OBIMKax
Tue, Oct 04, 2011, 10:58:38 PM
Outsourcing in Clinical Trials Northeast conference http://t.co/tyjO5Hth
Tue, Sep 27, 2011, 04:08:07 PM
CATEGORIES
Clinical Trials Testing
Data Management
Global Clinical Trials
Logistics
Quality Assurance
Specimen Management
ARCHIVE
July 2011
October 2011
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
December 2010
October 2010
TAGS
central lab services
GCP
DIA
DIA 2010
oncology
QA
quality assurance
biomarkers
esoteric testing
flow cytometry
CDISC
clinical trials
coagulation
cold chain logostics
CROs
CRP
data interoperability
data management in clinical trials
Applied Clinical Trials
basic safety testing
bio-chemistry
Bioclinica
central lab standards
CLIA
Clinical Insight
clinical research sites
clinical trial logistics
clinical trial management
clinical trial testing
GLP
Good Clinical Laboratory Practices (GCLP)
good clinical practices
hematology
HLA-B27
hybrid central lab
Research Triangle Park (RTP)
West Coast
Europe